This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
The desirability of a safe and inexpensive medical treatment that can improve a patient's health and sense of well-being has resulted in the growing use of complementary and alternative medicine (CAM) worldwide. Once considered fringe medicine, meditation, yoga, and other mind-body therapies—the most commonly practiced form of CAM—are increasingly practiced by patients with chronic neurologic disorders, such as multiple sclerosis (MS).1 In a recent survey, up to 67% of patients with MS reported the current use of at least one form of CAM, with most regarding their practice as complementary rather than as an alternative to conventional medicine.2 Despite the popularity of CAM, there is a paucity of well-designed clinical trials evaluating its use in MS; most studies are hampered by small sample size or lack of a control arm.
The study by Grossman et al.3 in this issue of Neurology® was a randomized, single-blind, controlled trial that investigated the effects of mindfulness-based meditation compared to usual care on depression and quality of life measures in 150 patients with MS. Patients with remitting-relapsing and secondary progressive MS with an Expanded Disability Status …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Topics Discussed
Alert Me
Recommended articles
A reassessment of the plateauing relationship between T2 lesion load and disability in MS
Autologous Hematopoietic Stem Cell Transplantation in Active Multiple Sclerosis
Siponimod and Cognition in Secondary Progressive Multiple Sclerosis
Association of Spectral-Domain OCT With Long-term Disability Worsening in Multiple Sclerosis